$7.84
1.82% yesterday
Nasdaq, Jul 14, 10:00 pm CET
ISIN
SG9999014716
Symbol
WVE
Sector
Industry

Wave Life Sciences Ltd. Stock price

$7.84
+0.99 14.45% 1M
-3.29 29.56% 6M
-4.53 36.62% YTD
+1.85 30.88% 1Y
+3.73 90.75% 3Y
-1.81 18.76% 5Y
-8.16 51.00% 10Y
-8.16 51.00% 20Y
Nasdaq, Closing price Mon, Jul 14 2025
+0.14 1.82%
ISIN
SG9999014716
Symbol
WVE
Sector
Industry

Key metrics

Basic
Market capitalization
$1.2b
Enterprise Value
$976.5m
Net debt
positive
Cash
$243.1m
Shares outstanding
154.1m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
11.6 | 20.2
EV/Sales
9.3 | 16.1
EV/FCF
negative
P/B
6.8
Financial Health
Equity Ratio
61.7%
Return on Equity
-44.6%
ROCE
-62.6%
ROIC
476.3%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$104.9m | $59.3m
EBITDA
$-122.0m | $-193.9m
EBIT
$-125.7m | $-180.6m
Net Income
$-112.3m | $-165.9m
Free Cash Flow
$-181.3m
Growth (TTM | estimate)
Revenue
-7.1% | -45.2%
EBITDA
-80.6% | -82.1%
EBIT
-74.2% | -63.6%
Net Income
-82.2% | -71.0%
Free Cash Flow
-30.0%
Margin (TTM | estimate)
Gross
-
EBITDA
-116.3% | -326.8%
EBIT
-119.8%
Net
-107.0% | -279.5%
Free Cash Flow
-172.8%
More
EPS
$-0.7
FCF per Share
$-1.2
Short interest
13.1%
Employees
288
Rev per Employee
$380.0k
Show more

Is Wave Life Sciences Ltd. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,006 stocks worldwide.

Wave Life Sciences Ltd. Stock Analysis

Unlock Scores for Free

Analyst Opinions

17 Analysts have issued a Wave Life Sciences Ltd. forecast:

15x Buy
88%
2x Hold
12%

Analyst Opinions

17 Analysts have issued a Wave Life Sciences Ltd. forecast:

Buy
88%
Hold
12%

Financial data from Wave Life Sciences Ltd.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
105 105
7% 7%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 64 64
21% 21%
61%
- Research and Development Expense 167 167
26% 26%
159%
-122 -122
81% 81%
-116%
- Depreciation and Amortization 3.73 3.73
19% 19%
4%
EBIT (Operating Income) EBIT -126 -126
74% 74%
-120%
Net Profit -112 -112
82% 82%
-107%

In millions USD.

Don't miss a Thing! We will send you all news about Wave Life Sciences Ltd. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Wave Life Sciences Ltd. Stock News

Positive
Seeking Alpha
7 days ago
Wave Life Sciences Ltd. is an innovative biotech with soli data for its AATD, Huntington's, and DMD programs. Its share price is nevertheless down 44% year-to-date, potentially creating a buying opportunity for a risk-on investor. Wave is partnered with GSK over its AATD program which recently demonstrated proof-of-concept and opens up the possibility of triple-digit million milestone payments.
Neutral
GlobeNewsWire
25 days ago
Presentation to highlight WVE-007 (INHBE GalNAc-siRNA) as a potential novel and unique obesity treatment leading to healthy weight loss and supporting preclinical data demonstrating potent and durable reduction in Activin E resulting in fat loss with muscle preservation
Neutral
GlobeNewsWire
about 2 months ago
CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd.
More Wave Life Sciences Ltd. News

Company Profile

Wave Life Sciences Ltd. is a biotechnology company, which engages in the development of proprietary synthetic chemistry drug. It focuses on the design, development, and commercialization of nucleic acid-based therapeutics. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Head office Singapore
CEO Paul Bolno
Employees 288
Founded 2012
Website www.wavelifesciences.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today